Showing results (431-440 of 476) with videos related to

Sort By:
Pageof 48
Investigational New Drugs|February 12, 2017
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase CKhaldoun Almhanna, Maria Luisa Limon Miron, David Wright, et al.
Pilot and Feasibility Studies|July 25, 2019
The Care Home Independent Prescribing Pharmacist Study (CHIPPS)-a non-randomised feasibility study of independent pharmacist prescribing in care homesJacqueline Inch, Frances Notman, Christine M Bond, et al.
ESC Heart Failure|December 26, 2024
Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registryIgnacio García-Bolao, Roy S Gardner, Daniel Gras, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 1, 2025
Aspirin, Birthweight, and Large-For-Gestational-Age Neonates: A Secondary Analysis of the ASPRE TrialDaniel L Rolnik, Liona C Poon, Argyro Syngelaki, et al.
Prenatal Diagnosis|February 1, 2008
Contingent screening for Down syndrome--results from the FaSTER trialHoward S Cuckle, Fergal D Malone, David Wright, et al.
Eneuro|March 30, 2016
Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain InjuryIla P Karve, Moses Zhang, Mark Habgood, et al.
Health Technology Assessment (Winchester, England)|March 24, 2026
Validating and updating the OHTS-EGPS model predicting 5-year glaucoma risk among patients with ocular hypertension using electronic medical records: a cohort studyDavid Wright, Hangjian Wu, Anthony King, et al.
Research in Social & Administrative Pharmacy : RSAP|November 30, 2025
The feasibility of implementing a hospital deprescribing behaviour change intervention and undertaking trial processes: A mixed methods evaluationSion Scott, Jacqueline Martin-Kerry, Megan Pritchard, et al.
Circulation|June 24, 2021
Pravastatin Versus Placebo in Pregnancies at High Risk of Term PreeclampsiaMoritz Döbert, Anna Nektaria Varouxaki, An Chi Mu, et al.
Antiviral Therapy|October 2, 2003
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adultsJacob P Lalezari, Edwin DeJesus, Donald W Northfelt, et al.
Pageof 48